Marziyeh Mousazadeh, Maryam Nikkhah, Negar Seyed, Sima Rafati, Saman Hosseinkhani
{"title":"Efficient Generation of Bone Marrow-Derived Murine Dendritic Cells: A Protocol Optimization Study.","authors":"Marziyeh Mousazadeh, Maryam Nikkhah, Negar Seyed, Sima Rafati, Saman Hosseinkhani","doi":"10.22034/iji.2026.108143.3086","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Dendritic cells (DCs) are the most potent antigen-presenting cells, playing a central role in T cell activation and the stimulation of B cell antibody production. Owing to their immunological significance, DCs have been extensively explored for applications in cancer immunotherapy, dendritic cell-based vaccines, and strategies to overcome the immunosuppressive tumor microenvironment.</p><p><strong>Objective: </strong>Given the broad applications of DCs and the need for efficient generation protocols, the present study aimed to optimize key parameters influencing the production of bone marrow-derived dendritic cells (BMDCs).</p><p><strong>Methods: </strong>Variables such as mouse strain, cytokine concentrations, culture plate type, differentiation duration, incubation temperature, cell seeding density, and media replacement intervals were evaluated. CD11c expression was used as the primary marker to quantify BMDCs, while CD80 and CD86 were used as indicators of maturation status.</p><p><strong>Results: </strong>The optimized protocol yielded 60-70% CD11c+ BMDCs and 70-80% CD80/CD86 expression within 5 days.</p><p><strong>Conclusion: </strong>This robust and highly reproducible protocol offers valuable applications for in vitro dendritic cell generation studies.</p>","PeriodicalId":54921,"journal":{"name":"Iranian Journal of Immunology","volume":"23 1","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.22034/iji.2026.108143.3086","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Dendritic cells (DCs) are the most potent antigen-presenting cells, playing a central role in T cell activation and the stimulation of B cell antibody production. Owing to their immunological significance, DCs have been extensively explored for applications in cancer immunotherapy, dendritic cell-based vaccines, and strategies to overcome the immunosuppressive tumor microenvironment.
Objective: Given the broad applications of DCs and the need for efficient generation protocols, the present study aimed to optimize key parameters influencing the production of bone marrow-derived dendritic cells (BMDCs).
Methods: Variables such as mouse strain, cytokine concentrations, culture plate type, differentiation duration, incubation temperature, cell seeding density, and media replacement intervals were evaluated. CD11c expression was used as the primary marker to quantify BMDCs, while CD80 and CD86 were used as indicators of maturation status.
Results: The optimized protocol yielded 60-70% CD11c+ BMDCs and 70-80% CD80/CD86 expression within 5 days.
Conclusion: This robust and highly reproducible protocol offers valuable applications for in vitro dendritic cell generation studies.
期刊介绍：
The Iranian Journal of Immunology (I.J.I) is an internationally disseminated peer-reviewed publication and publishes a broad range of experimental and theoretical studies concerned with all aspects of immunology.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
